Collegium Pharmaceutical, Inc. Inventory, Finished Goods, Gross
Collegium Pharmaceutical, Inc. (COLL) had Inventory, Finished Goods, Gross of $36.05 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Gross $36.05M.
- 2026-03-31: Inventory, Finished Goods, Gross $21.20M.
- 2025-12-31: Inventory, Finished Goods, Gross $20.87M.
- 2024-12-31: Inventory, Finished Goods, Gross $17.81M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2026-06-30 | $36.05M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $21.20M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $20.87M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $17.81M 10-K · filed 2026-02-26 |
| 2024-09-30 | $16.44M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $14.78M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $13.30M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $15.21M 10-K · filed 2025-02-27 |
| 2023-09-30 | $10.55M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $12.53M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $13.72M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $16.23M 10-K · filed 2024-02-22 |
| 2022-09-30 | $21.72M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $23.43M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $36.88M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $12.70M 10-K · filed 2023-02-23 |
| 2021-09-30 | $10.70M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $9.50M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $9.69M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $11.00M 10-K · filed 2022-02-24 |
| 2020-09-30 | $10.71M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.02M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $8.65M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $7.42M 10-K · filed 2021-02-25 |
| 2019-09-30 | $6.34M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $7.44M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.94M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $6.65M 10-K · filed 2020-02-27 |
| 2018-09-30 | $7.77M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $7.49M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $6.87M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $875.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $634.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.12M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.02M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $955.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | $1.14M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.17M 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |